scPharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
scPharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • scPharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.28M, a 9.32% decline year-over-year.
  • scPharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $5.44M, a 12.1% increase year-over-year.
  • scPharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.44M, a 12.1% increase from 2023.
  • scPharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.86M, a 71.1% increase from 2022.
  • scPharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.84M, a 19.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.44M +$586K +12.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-19
2023 $4.86M +$2.02M +71.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-19
2022 $2.84M +$472K +19.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $2.37M +$366K +18.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $2M +$551K +38% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $1.45M -$686K -32.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 $2.14M +$1.19M +125% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 $947K +$71K +8.11% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 $876K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.